Related topics: dementia , brain , nerve cells , memory , cognitive decline
Alzheimer's disease
hideAlzheimer's disease (AD), also called Alzheimer disease, Senile Dementia of the Alzheimer Type (SDAT) or simply Alzheimer's, is the most common form of dementia. This incurable, degenerative, and terminal disease was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him. Generally it is diagnosed in people over 65 years of age, although the less-prevalent early-onset Alzheimer's can occur much earlier. An estimated 26.6 million people worldwide had Alzheimer's in 2006; this number may quadruple by 2050.
Although each sufferer experiences Alzheimer's in a unique way, there are many common symptoms. The earliest observable symptoms are often mistakenly thought to be 'age-related' concerns, or manifestations of stress. In the early stages, the most commonly recognised symptom is memory loss, such as difficulty in remembering recently learned facts. When a doctor or physician has been notified, and AD is suspected, the diagnosis is usually confirmed with behavioural assessments and cognitive tests, often followed by a brain scan if available. As the disease advances, symptoms include confusion, irritability and aggression, mood swings, language breakdown, long-term memory loss, and the general withdrawal of the sufferer as their senses decline. Gradually, bodily functions are lost, ultimately leading to death. Individual prognosis is difficult to assess, as the duration of the disease varies. AD develops for an indeterminate period of time before becoming fully apparent, and it can progress undiagnosed for years. The mean life expectancy following diagnosis is approximately seven years. Fewer than three percent of individuals live more than fourteen years after diagnosis.
The cause and progression of Alzheimer's disease are not well understood. Research indicates that the disease is associated with plaques and tangles in the brain. Currently used treatments offer a small symptomatic benefit; no treatments to delay or halt the progression of the disease are as yet available. As of 2008, more than 500 clinical trials were investigating possible treatments for AD, but it is unknown if any of them will prove successful. Many measures have been suggested for the prevention of Alzheimer's disease, but their value is unproven in slowing the course and reducing the severity of the disease. Mental stimulation, exercise, and a balanced diet are often recommended, as both a possible prevention and a sensible way of managing the disease.
Because AD cannot be cured and is degenerative, management of patients is essential. The role of the main caregiver is often taken by the spouse or a close relative. Alzheimer's disease is known for placing a great burden on caregivers; the pressures can be wide-ranging, involving social, psychological, physical, and economic elements of the caregiver's life. In developed countries, AD is one of the most economically costly diseases to society.
For more information about Alzheimer's disease, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
News tagged with alzheimer s disease
Canadian police consider GPS for people with Alzheimer's
Electronics / Consumer & Gadgets
Dec 23, 2009 |
4 / 5 (2) |
1
Police in Montreal are studying the possibility of offering GPS bracelets to people suffering from Alzheimer's disease, an official told AFP.
What's his name again? How celebrity monikers can help us remember
Dec 18, 2009 |
not rated yet |
0
Famous mugs do more than prompt us into buying magazines, according to new Université de Montréal research. In the December issue of the Canadian Journal on Aging, a team of scientists explain how the abilit ...
Diet high in methionine could increase risk of Alzheimers
Dec 16, 2009 |
3.1 / 5 (14) |
8
(PhysOrg.com) -- Temple study suggests that an amino acid found in red meats, fish, beans and other foods may increase possibility of dementia.
Higher levels of protein hormone associated with lower risk of dementia, Alzheimer's disease
Dec 15, 2009 |
5 / 5 (1) |
0
Persons with higher levels of leptin, a protein hormone produced by fat cells and involved in the regulation of appetite, may have an associated reduced incidence of Alzheimer disease and dementia, according to a study in ...
Delaying the aging process protects against Alzheimer's disease
Medicine & Health / Neuroscience
Dec 10, 2009 |
4 / 5 (5) |
0
Aging is the single greatest risk factor for Alzheimer's disease. In their latest study, researchers at the Salk Institute for Biological Studies found that simply slowing the aging process in mice prone to ...
Family's inherited condition links prion diseases, Alzheimer's
Medicine & Health / Neuroscience
Dec 09, 2009 |
4.5 / 5 (2) |
0
(PhysOrg.com) -- A laboratory connection between Alzheimer's disease and brain-wasting diseases such as the human form of mad cow disease has moved into the clinic for what is believed to be the first time, manifesting itself ...
Drug for Alzheimer's disease does not appear to slow cognitive decline
Medicine & Health / Medications
Dec 15, 2009 |
not rated yet |
0
Although there were promising results in a phase 2 trial, patients with mild Alzheimer disease who received the drug tarenflurbil as part of a phase 3 trial did not have better outcomes on measures of cognitive decline or ...
Imaging test detects Alzheimer's disease that is likely to progress
Dec 15, 2009 |
not rated yet |
0
Early Alzheimer's disease detected by a compound that binds to brain plaques appears likely to progress into symptomatic Alzheimer's disease with dementia, according to a report in the December issue of Archives of Neurology, one of ...


